Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer.
Mashiro OkunakaDaisuke KotaniKen DemachiAkihito KawazoeTakayuki YoshinoToshikatsu KawasakiKohei ShitaraPublished in: BMC cancer (2020)
The combination of nab-PTX plus RAM showed a similar efficacy and safety profile to PTX plus RAM as second-line treatment for patients with AGC.